Pulmozyme, Inhalationslösung

7680526230148 CH-52623 Inhalationslösung

Associated product:

PULMOZYME sol inhal 2.5 mg/2.5 ml 30 amp
Pulmozyme, Inhalationslösung
Pulmozyme, Inhalationslösung
Pulmozyme, Inhalationslösung
1 / 3
google

Article details

Package size
5 x 6
Selling units
30
Measure
Ampulle(n)
Galenic form
Inhalationslösung
Galenic group
Inhalation

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/05/2021
Summary of Product Characteristics
Français
06/05/2021
Summary of Product Characteristics
Italien
06/05/2021
Patient information leaflet
Allemand
05/05/2021
Patient information leaflet
Français
05/05/2021
Patient information leaflet
Italien
05/05/2021

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 761.00
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1995

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
52623
Drug name
Pulmozyme, Inhalationslösung
Galenic form
LSVE
ATC Code
R05CB13
Authorization status
Z
Dispensing category
B
First authorization
28/04/1994
Authorization expiration date
31/12/9999
IT Number
03.02.0.
Domain
Human medicine
Field of application
Zystische Fibrose, in Kombination mit einer Standardtherapie

Package details

Description (FR)
PULMOZYME sol inhal 2.5 mg/2.5 ml 30 amp
Description (DE)
PULMOZYME Inhal Lös 2.5 mg/2.5 ml 30 Amp
Market launch
28/04/1994
Narcotic (BTM)
No